北美生物样本库市场预测至 2028 年 - 按产品和服务（设备、消耗品、服务和软件）、样本（血液制品、人体组织、细胞系等）和应用（再生医学）划分的 COVID-19 影响和区域分析、生命科学研究和临床研究）
No. of Pages: 172 | Report Code: TIPRE00027964 | Category: Life Sciences
No. of Pages: 172 | Report Code: TIPRE00027964 | Category: Life Sciences
COVID-19 大流行是千载难逢的事件，迄今为止， -对世界各地的医疗保健、经济和社会产生影响。北美的医疗保健系统在估计 COVID-19 影响的人口统计方面面临着迫在眉睫的问题。在缺乏准确数据的情况下，提前实施了封锁，这使得医疗保健系统在照顾需要立即关注的非 COVID-19 患者方面承受着更大的压力。封锁对该地区的物流和供应线产生了直接影响，进而影响了该地区的医疗保健服务。在 COVID-19 的早期阶段，加拿大的生物样本库活动被认为是非必要的医疗保健服务，但随着必要的研究行动开始，与 COVID-19 相关的研究被允许并启动。由于这一发展，生物样本库成为一项必要的服务，可以加快 COVID-19 研究速度并持续开展关键研究工作。疫情期间，应对稀缺且竞争频繁的医疗保健供应链对于持续运营需求至关重要。生物银行必须购买额外的个人防护装备 (PPE)，以保护其人员免受 COVID-19 的侵害，甚至员工也必须定期检查是否有可疑的 COVID-19 症状。生物样本库必须在全球范围内进行沟通和搜索，以获取快速收集和存储样本所需的材料。由于有大量与 COVID-19 相关的临床试验，生物样本库对于收集和保存血浆、血清、DNA 和 RNA 等生物样本、临床数据和基因组数据至关重要。
;
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动北美生物样本库市场的发展。北美生物样本库市场预计在预测期内将以良好的复合年增长率增长。
Strategic insights for North America Biobanks involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 875.19 Million |
| Market Size by 2028 | US$ 1,386.56 Million |
| Global CAGR (2021 - 2028) | 6.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品和服务
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Biobanks refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Biobanks Market is valued at US$ 875.19 Million in 2021, it is projected to reach US$ 1,386.56 Million by 2028.
As per our report North America Biobanks Market, the market size is valued at US$ 875.19 Million in 2021, projecting it to reach US$ 1,386.56 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.
The North America Biobanks Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Biobanks Market report:
The North America Biobanks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Biobanks Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Biobanks Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Biobanks Market
